Mohammad Mahfuz Ali Khan Shawan, Ashish Ranjan Sharma, Sajal Kumar Halder, Tawsif Al Arian et al.
A vaccine is defined as a biologic preparation that trains the immune system, boosts immunity, and protects against a deadly microbial infection. They have been used for centuries to combat a variety of contagious illnesses by means of subsiding the disease burden as well as eradicating the disease....
Mohammad Mahfuz Ali Khan Shawan, Ashish Ranjan Sharma, Manojit Bhattacharya, Bidyut Mallik et al.
The devastating outbreak of COVID-19 has spread all over the world and has become a global health concern. There is no specific therapeutics to encounter the COVID-19. Small interfering RNA (siRNA)-based therapy is an efficient strategy to control human viral infections employing post-transcriptiona...
Rajesh Sharma, Hedayat Abbastabar, Deldar Morad Abdulah, Hassan Abidi et al.
Background: Cancers represent a challenging public health threat in Asia. This study examines the temporal patterns of incidence, mortality, disability and risk factors of 29 cancers in Asia in the last three decades. Methods: The age, sex and year-wise estimates of incidence, mortality, and disabil...
Kshitij Jagtap, R Naveen, Jessica Day, Parikshit Sen et al.
OBJECTIVE: Flares of autoimmune rheumatic diseases (AIRDs) following COVID-19 vaccination are a particular concern in vaccine-hesitant individuals. Therefore, we investigated the incidence, predictors and patterns of flares following vaccination in individuals living with AIRDs, using global COVID-1...
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, Sanjiban Sekhar Roy et al.
The medicine and healthcare sector has been evolving and advancing very fast. The advancement has been initiated and shaped by the applications of data-driven, robust, and efficient machine learning (ML) to deep learning (DL) technologies. ML in the medical sector is developing quickly, causing rapi...
Parikshit Sen, R Naveen, Nazanin Houshmand, Siamak Moghadam‐Kia et al.
OBJECTIVE: COVID-19 vaccines have a favorable safety profile in patients with autoimmune rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however, hesitancy continues to persist among these patients. Therefore, we studied the prevalence, predictors and reasons for hesita...
Bohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, Jessica Day et al.
Limited evidence on long-term COVID-19 vaccine safety in patients with idiopathic inflammatory myopathies (IIMs) continues to contribute to vaccine hesitancy. We studied delayed-onset vaccine adverse events (AEs) in patients with IIMs, other systemic autoimmune and inflammatory disorders (SAIDs), an...
R Naveen, Parikshit Sen, Zoltán Griger, Jessica Day et al.
OBJECTIVES: Disease flares in the post-coronavirus disease 2019 (COVID-19) vaccination period represent a prominent concern, though risk factors are poorly understood. We studied these flares among patients with idiopathic inflammatory myopathies (IIMs) and other autoimmune rheumatic diseases (AIRDs...
R Naveen, Darpan R. Thakare, Masataka Kuwana, John D Pauling et al.
The safety profile of COVID-19 vaccines is understudied in patients with systemic sclerosis (SSc). We compared short-term adverse events (AEs) 7 days following vaccination in patients with SSc vs other rheumatic (AIRDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs). The COV...
Sasha Saadia Ali, R Naveen, Parikshit Sen, Jessica Day et al.
[No abstract]
Alessia Alunno, Francesco Carubbi, Ai Lyn Tan, Parikshit Sen et al.
Notwithstanding the wealth of literature on COVID-19, studies focusing on young adults with autoimmune diseases (AD) are lacking. To determine early (within 7 days) and late (after 7 days) anti-SARS-CoV-2 vaccine-related adverse events (AEs), post-vaccine disease flares, COVID-19 severity and breakt...
Sajal Kumar Halder, Ashish Ranjan Sharma, Tawsif Al Arian, Samantha Saha et al.
Background: The continuously emerging novel strains of SARS-CoV-2 remain a menace to the global population. The vicious delta variant (originated in India) is considered one of the most infectious/contagious variants of SARS-CoV-2. The transmission frequency of this variant is 225% higher than other...
Akira Yoshida, Yuan Li, Vahed Maroufy, Masataka Kuwana et al.
Abstract Objectives To investigate health-related quality of life in patients with idiopathic inflammatory myopathies (IIMs) compared with those with non-IIM autoimmune rheumatic diseases (AIRDs), non-rheumatic autoimmune diseases (nrAIDs) and without autoimmune diseases (controls) using Patient-Rep...
Mrinalini Dey, R Naveen, Elena Nikiphorou, Parikshit Sen et al.
[No abstract]
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, Chih‐Wei Tseng et al.
COVID-19 has been suggested as a possible trigger of disease flares in patients with rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown. This study aimed to identify factors associated with breakthrough infection (BIs) and disease flares in patients with RA fol...